![T-cell masthead image](https://www.soligenix.com/wp-content/uploads/2019/06/default-masthead2-id538032878.jpg)
Journal of the American Medical Association Dermatology – Efficacy and Safety of Topical Hypericin Photodynamic Therapy for Early-Stage Cutaneous T-Cell Lymphoma (Mycosis Fungoides)
The results of the successful Phase 3 FLASH (Fluorescent Light Activated Synthetic Hypericin) study evaluating HyBryte™ (synthetic hypericin) for the treatment of cutaneous T-cell lymphoma (CTCL) has been published in the Journal of the American Medical Association (JAMA) Dermatology. Read the publication.